Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer
OBJECTIVEBoth the apparent diffusion coefficient (ADC) acquired by diffusion-weighted magnetic resonance imaging (DW-MRI) and the standardized uptake value (SUV), acquired by F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT), are well-established functional paramet...
Gespeichert in:
Veröffentlicht in: | Nuclear medicine communications 2018-01, Vol.39 (1), p.60-67 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 67 |
---|---|
container_issue | 1 |
container_start_page | 60 |
container_title | Nuclear medicine communications |
container_volume | 39 |
creator | Goense, Lucas Heethuis, Sophie E van Rossum, Peter S.N Voncken, Francine E.M Lagendijk, Jan J.W Lam, Marnix G.E.H Terhaard, Chris H van Hillegersberg, Richard Ruurda, Jelle P Mook, Stella van Lier, Astrid L.H.M.W Lin, Steven H Meijer, Gert J |
description | OBJECTIVEBoth the apparent diffusion coefficient (ADC) acquired by diffusion-weighted magnetic resonance imaging (DW-MRI) and the standardized uptake value (SUV), acquired by F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT), are well-established functional parameters in cancer imaging. Currently, it is unclear whether these two markers provide complementary prognostic and predictive information in esophageal cancer. The aim of this study was to evaluate the correlation between ADC and SUV in patients with esophageal cancer.
MATERIALS AND METHODSThis prospective study included 76 patients with histologically proven esophageal cancer who underwent both DW-MRI and F-FDG PET/CT examinations before treatment. The minimum and mean ADC values (ADCmin and ADCmean) of the primary tumor were assessed on MRI. Similarly, the glucose metabolism was evaluated by the maximum and mean SUV (SUVmax and SUVmean) in the same lesions on F-FDG PET/CT images. Spearman’s rank correlation coefficients were used to assess the correlation between tumor ADC and SUV values.
RESULTSThe tumor ADC and SUV values as measures of cell density and glucose metabolism, respectively, showed negligible nonsignificant correlations (ADCmin vs. SUVmaxr=−0.087, P=0.457; ADCmin vs. SUVmeanr=−0.105, P=0.369; ADCmean vs. SUVmaxr=−0.099, P=0.349; ADCmean vs. SUVmeanr=−0.111, P=0.340). No differences in tumor ADC and SUV values were observed between the different histologic tumor types, stages, and differentiation grades.
CONCLUSIONThis study indicates that tumor cellularity derived from DW-MRI and tumor metabolism measured by F-FDG PET/CT are independent cellular phenomena in newly diagnosed esophageal cancer. Therefore, tumor ADC and SUV values may play complementary roles as imaging markers in the prediction of survival and evaluation of response to treatment in esophageal cancer. |
doi_str_mv | 10.1097/MNM.0000000000000771 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1973459846</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1973459846</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2011-f8721a24d07cacf66cc9984b36fad7eab7e77c0c7fcf29b350b7f6625b9ccbd03</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMobk7_gUguvemWNG3SXsrc5mBTkXld0vSkq_ZjJq1Df70ZmyJeeG4OHJ73PfAgdEnJkJJYjJb3yyH5PULQI9SngWBeyP3oGPUJDZjHOOM9dGbti2MixsUp6vkx8RljvI8-x40xUMq2aGqcQrsFqLHuarU7yBIXlcyLOseVNK9gLM7AFO-QYW2aCmeF1p11oLeFIl-37r58mmNZZ5hGU296O8OPk9VovMJFjcE2m7XMwZUqWSsw5-hEy9LCxWEP0PN0shrfeYuH2Xx8s_CUTyj1dCR8Kv0gI0JJpTlXKo6jIGVcy0yATAUIoYgSWmk_TllIUuEoP0xjpdKMsAG63vduTPPWgW2TqrAKylLW0HQ2obFgQegquUODPapMY60BnWyMM2A-EkqSnfXEWU_-Wnexq8OHLq0g-wl9a3ZAtAe2Tdk6ja9ltwWTrJ2Mdv1_9xeYMo8o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1973459846</pqid></control><display><type>article</type><title>Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><creator>Goense, Lucas ; Heethuis, Sophie E ; van Rossum, Peter S.N ; Voncken, Francine E.M ; Lagendijk, Jan J.W ; Lam, Marnix G.E.H ; Terhaard, Chris H ; van Hillegersberg, Richard ; Ruurda, Jelle P ; Mook, Stella ; van Lier, Astrid L.H.M.W ; Lin, Steven H ; Meijer, Gert J</creator><creatorcontrib>Goense, Lucas ; Heethuis, Sophie E ; van Rossum, Peter S.N ; Voncken, Francine E.M ; Lagendijk, Jan J.W ; Lam, Marnix G.E.H ; Terhaard, Chris H ; van Hillegersberg, Richard ; Ruurda, Jelle P ; Mook, Stella ; van Lier, Astrid L.H.M.W ; Lin, Steven H ; Meijer, Gert J</creatorcontrib><description>OBJECTIVEBoth the apparent diffusion coefficient (ADC) acquired by diffusion-weighted magnetic resonance imaging (DW-MRI) and the standardized uptake value (SUV), acquired by F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT), are well-established functional parameters in cancer imaging. Currently, it is unclear whether these two markers provide complementary prognostic and predictive information in esophageal cancer. The aim of this study was to evaluate the correlation between ADC and SUV in patients with esophageal cancer.
MATERIALS AND METHODSThis prospective study included 76 patients with histologically proven esophageal cancer who underwent both DW-MRI and F-FDG PET/CT examinations before treatment. The minimum and mean ADC values (ADCmin and ADCmean) of the primary tumor were assessed on MRI. Similarly, the glucose metabolism was evaluated by the maximum and mean SUV (SUVmax and SUVmean) in the same lesions on F-FDG PET/CT images. Spearman’s rank correlation coefficients were used to assess the correlation between tumor ADC and SUV values.
RESULTSThe tumor ADC and SUV values as measures of cell density and glucose metabolism, respectively, showed negligible nonsignificant correlations (ADCmin vs. SUVmaxr=−0.087, P=0.457; ADCmin vs. SUVmeanr=−0.105, P=0.369; ADCmean vs. SUVmaxr=−0.099, P=0.349; ADCmean vs. SUVmeanr=−0.111, P=0.340). No differences in tumor ADC and SUV values were observed between the different histologic tumor types, stages, and differentiation grades.
CONCLUSIONThis study indicates that tumor cellularity derived from DW-MRI and tumor metabolism measured by F-FDG PET/CT are independent cellular phenomena in newly diagnosed esophageal cancer. Therefore, tumor ADC and SUV values may play complementary roles as imaging markers in the prediction of survival and evaluation of response to treatment in esophageal cancer.</description><identifier>ISSN: 0143-3636</identifier><identifier>EISSN: 1473-5628</identifier><identifier>DOI: 10.1097/MNM.0000000000000771</identifier><identifier>PMID: 29023336</identifier><language>eng</language><publisher>England: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Aged ; Biological Transport ; Biomarkers, Tumor - metabolism ; Diffusion Magnetic Resonance Imaging ; Esophageal Neoplasms - diagnostic imaging ; Esophageal Neoplasms - metabolism ; Esophageal Neoplasms - pathology ; Female ; Fluorodeoxyglucose F18 ; Humans ; Male ; Middle Aged ; Positron Emission Tomography Computed Tomography ; Tumor Burden</subject><ispartof>Nuclear medicine communications, 2018-01, Vol.39 (1), p.60-67</ispartof><rights>Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2011-f8721a24d07cacf66cc9984b36fad7eab7e77c0c7fcf29b350b7f6625b9ccbd03</citedby><cites>FETCH-LOGICAL-c2011-f8721a24d07cacf66cc9984b36fad7eab7e77c0c7fcf29b350b7f6625b9ccbd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29023336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goense, Lucas</creatorcontrib><creatorcontrib>Heethuis, Sophie E</creatorcontrib><creatorcontrib>van Rossum, Peter S.N</creatorcontrib><creatorcontrib>Voncken, Francine E.M</creatorcontrib><creatorcontrib>Lagendijk, Jan J.W</creatorcontrib><creatorcontrib>Lam, Marnix G.E.H</creatorcontrib><creatorcontrib>Terhaard, Chris H</creatorcontrib><creatorcontrib>van Hillegersberg, Richard</creatorcontrib><creatorcontrib>Ruurda, Jelle P</creatorcontrib><creatorcontrib>Mook, Stella</creatorcontrib><creatorcontrib>van Lier, Astrid L.H.M.W</creatorcontrib><creatorcontrib>Lin, Steven H</creatorcontrib><creatorcontrib>Meijer, Gert J</creatorcontrib><title>Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer</title><title>Nuclear medicine communications</title><addtitle>Nucl Med Commun</addtitle><description>OBJECTIVEBoth the apparent diffusion coefficient (ADC) acquired by diffusion-weighted magnetic resonance imaging (DW-MRI) and the standardized uptake value (SUV), acquired by F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT), are well-established functional parameters in cancer imaging. Currently, it is unclear whether these two markers provide complementary prognostic and predictive information in esophageal cancer. The aim of this study was to evaluate the correlation between ADC and SUV in patients with esophageal cancer.
MATERIALS AND METHODSThis prospective study included 76 patients with histologically proven esophageal cancer who underwent both DW-MRI and F-FDG PET/CT examinations before treatment. The minimum and mean ADC values (ADCmin and ADCmean) of the primary tumor were assessed on MRI. Similarly, the glucose metabolism was evaluated by the maximum and mean SUV (SUVmax and SUVmean) in the same lesions on F-FDG PET/CT images. Spearman’s rank correlation coefficients were used to assess the correlation between tumor ADC and SUV values.
RESULTSThe tumor ADC and SUV values as measures of cell density and glucose metabolism, respectively, showed negligible nonsignificant correlations (ADCmin vs. SUVmaxr=−0.087, P=0.457; ADCmin vs. SUVmeanr=−0.105, P=0.369; ADCmean vs. SUVmaxr=−0.099, P=0.349; ADCmean vs. SUVmeanr=−0.111, P=0.340). No differences in tumor ADC and SUV values were observed between the different histologic tumor types, stages, and differentiation grades.
CONCLUSIONThis study indicates that tumor cellularity derived from DW-MRI and tumor metabolism measured by F-FDG PET/CT are independent cellular phenomena in newly diagnosed esophageal cancer. Therefore, tumor ADC and SUV values may play complementary roles as imaging markers in the prediction of survival and evaluation of response to treatment in esophageal cancer.</description><subject>Aged</subject><subject>Biological Transport</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Diffusion Magnetic Resonance Imaging</subject><subject>Esophageal Neoplasms - diagnostic imaging</subject><subject>Esophageal Neoplasms - metabolism</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Tumor Burden</subject><issn>0143-3636</issn><issn>1473-5628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1LwzAUhoMobk7_gUguvemWNG3SXsrc5mBTkXld0vSkq_ZjJq1Df70ZmyJeeG4OHJ73PfAgdEnJkJJYjJb3yyH5PULQI9SngWBeyP3oGPUJDZjHOOM9dGbti2MixsUp6vkx8RljvI8-x40xUMq2aGqcQrsFqLHuarU7yBIXlcyLOseVNK9gLM7AFO-QYW2aCmeF1p11oLeFIl-37r58mmNZZ5hGU296O8OPk9VovMJFjcE2m7XMwZUqWSsw5-hEy9LCxWEP0PN0shrfeYuH2Xx8s_CUTyj1dCR8Kv0gI0JJpTlXKo6jIGVcy0yATAUIoYgSWmk_TllIUuEoP0xjpdKMsAG63vduTPPWgW2TqrAKylLW0HQ2obFgQegquUODPapMY60BnWyMM2A-EkqSnfXEWU_-Wnexq8OHLq0g-wl9a3ZAtAe2Tdk6ja9ltwWTrJ2Mdv1_9xeYMo8o</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Goense, Lucas</creator><creator>Heethuis, Sophie E</creator><creator>van Rossum, Peter S.N</creator><creator>Voncken, Francine E.M</creator><creator>Lagendijk, Jan J.W</creator><creator>Lam, Marnix G.E.H</creator><creator>Terhaard, Chris H</creator><creator>van Hillegersberg, Richard</creator><creator>Ruurda, Jelle P</creator><creator>Mook, Stella</creator><creator>van Lier, Astrid L.H.M.W</creator><creator>Lin, Steven H</creator><creator>Meijer, Gert J</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201801</creationdate><title>Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer</title><author>Goense, Lucas ; Heethuis, Sophie E ; van Rossum, Peter S.N ; Voncken, Francine E.M ; Lagendijk, Jan J.W ; Lam, Marnix G.E.H ; Terhaard, Chris H ; van Hillegersberg, Richard ; Ruurda, Jelle P ; Mook, Stella ; van Lier, Astrid L.H.M.W ; Lin, Steven H ; Meijer, Gert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2011-f8721a24d07cacf66cc9984b36fad7eab7e77c0c7fcf29b350b7f6625b9ccbd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Biological Transport</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Diffusion Magnetic Resonance Imaging</topic><topic>Esophageal Neoplasms - diagnostic imaging</topic><topic>Esophageal Neoplasms - metabolism</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Tumor Burden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goense, Lucas</creatorcontrib><creatorcontrib>Heethuis, Sophie E</creatorcontrib><creatorcontrib>van Rossum, Peter S.N</creatorcontrib><creatorcontrib>Voncken, Francine E.M</creatorcontrib><creatorcontrib>Lagendijk, Jan J.W</creatorcontrib><creatorcontrib>Lam, Marnix G.E.H</creatorcontrib><creatorcontrib>Terhaard, Chris H</creatorcontrib><creatorcontrib>van Hillegersberg, Richard</creatorcontrib><creatorcontrib>Ruurda, Jelle P</creatorcontrib><creatorcontrib>Mook, Stella</creatorcontrib><creatorcontrib>van Lier, Astrid L.H.M.W</creatorcontrib><creatorcontrib>Lin, Steven H</creatorcontrib><creatorcontrib>Meijer, Gert J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nuclear medicine communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goense, Lucas</au><au>Heethuis, Sophie E</au><au>van Rossum, Peter S.N</au><au>Voncken, Francine E.M</au><au>Lagendijk, Jan J.W</au><au>Lam, Marnix G.E.H</au><au>Terhaard, Chris H</au><au>van Hillegersberg, Richard</au><au>Ruurda, Jelle P</au><au>Mook, Stella</au><au>van Lier, Astrid L.H.M.W</au><au>Lin, Steven H</au><au>Meijer, Gert J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer</atitle><jtitle>Nuclear medicine communications</jtitle><addtitle>Nucl Med Commun</addtitle><date>2018-01</date><risdate>2018</risdate><volume>39</volume><issue>1</issue><spage>60</spage><epage>67</epage><pages>60-67</pages><issn>0143-3636</issn><eissn>1473-5628</eissn><abstract>OBJECTIVEBoth the apparent diffusion coefficient (ADC) acquired by diffusion-weighted magnetic resonance imaging (DW-MRI) and the standardized uptake value (SUV), acquired by F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT), are well-established functional parameters in cancer imaging. Currently, it is unclear whether these two markers provide complementary prognostic and predictive information in esophageal cancer. The aim of this study was to evaluate the correlation between ADC and SUV in patients with esophageal cancer.
MATERIALS AND METHODSThis prospective study included 76 patients with histologically proven esophageal cancer who underwent both DW-MRI and F-FDG PET/CT examinations before treatment. The minimum and mean ADC values (ADCmin and ADCmean) of the primary tumor were assessed on MRI. Similarly, the glucose metabolism was evaluated by the maximum and mean SUV (SUVmax and SUVmean) in the same lesions on F-FDG PET/CT images. Spearman’s rank correlation coefficients were used to assess the correlation between tumor ADC and SUV values.
RESULTSThe tumor ADC and SUV values as measures of cell density and glucose metabolism, respectively, showed negligible nonsignificant correlations (ADCmin vs. SUVmaxr=−0.087, P=0.457; ADCmin vs. SUVmeanr=−0.105, P=0.369; ADCmean vs. SUVmaxr=−0.099, P=0.349; ADCmean vs. SUVmeanr=−0.111, P=0.340). No differences in tumor ADC and SUV values were observed between the different histologic tumor types, stages, and differentiation grades.
CONCLUSIONThis study indicates that tumor cellularity derived from DW-MRI and tumor metabolism measured by F-FDG PET/CT are independent cellular phenomena in newly diagnosed esophageal cancer. Therefore, tumor ADC and SUV values may play complementary roles as imaging markers in the prediction of survival and evaluation of response to treatment in esophageal cancer.</abstract><cop>England</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>29023336</pmid><doi>10.1097/MNM.0000000000000771</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0143-3636 |
ispartof | Nuclear medicine communications, 2018-01, Vol.39 (1), p.60-67 |
issn | 0143-3636 1473-5628 |
language | eng |
recordid | cdi_proquest_miscellaneous_1973459846 |
source | Journals@Ovid Ovid Autoload; MEDLINE |
subjects | Aged Biological Transport Biomarkers, Tumor - metabolism Diffusion Magnetic Resonance Imaging Esophageal Neoplasms - diagnostic imaging Esophageal Neoplasms - metabolism Esophageal Neoplasms - pathology Female Fluorodeoxyglucose F18 Humans Male Middle Aged Positron Emission Tomography Computed Tomography Tumor Burden |
title | Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T05%3A25%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20between%20functional%20imaging%20markers%20derived%20from%20diffusion-weighted%20MRI%20and%2018F-FDG%20PET/CT%20in%20esophageal%20cancer&rft.jtitle=Nuclear%20medicine%20communications&rft.au=Goense,%20Lucas&rft.date=2018-01&rft.volume=39&rft.issue=1&rft.spage=60&rft.epage=67&rft.pages=60-67&rft.issn=0143-3636&rft.eissn=1473-5628&rft_id=info:doi/10.1097/MNM.0000000000000771&rft_dat=%3Cproquest_cross%3E1973459846%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1973459846&rft_id=info:pmid/29023336&rfr_iscdi=true |